Article

Automata has completed a $45 million Series C funding round led by Dimension, with Danaher Ventures participating as a strategic investor. This funding will accelerate the development of the LINQ lab automation platform, which utilizes modular robotics and orchestration software for programmable lab environments.

Murali Venkatesan from Danaher joins Automata's board, and the partnership enhances LINQ's integration with Molecular Devices and Beckman Coulter Life Sciences. Automata reports five major pharmaceutical companies as clients, with plans to use the investment for global customer deployment and next-generation software development. The funding round also included Tru Arrow Partners, Octopus Ventures, and Entrepreneurs First.